•Commercialization / Manufacturing
•Greenfield opportunities in the SE
•Diversification outside of pharmaceuticals
–Agricultural
–Chemical/Environmental
•International Programs (Europe & Asia)
•Good IPO market
•Equity market returning to biotechnology
–Pharmaceuticals/biotechnology
•
•